HPLC and Mass Spectrometry Answer Different Questions
Two analytical methods appear on almost every peptide specification, and they are routinely treated as a single quality score. They are not interchangeable. HPLC answers how much of the material is the main component. Mass spectrometry answers whether that component is the intended molecule. Each is silent on the other's question, and both are silent on a third.
Reverse-phase HPLC separates a mixture by how strongly its components interact with a stationary phase, then measures what elutes. The output is a chromatogram: peaks in time order, with areas that can be integrated. From that, a proportion — the main peak as a fraction of total detected peak area. It is fundamentally a counting exercise performed on things that have been pulled apart.
Mass spectrometry ionises the material and measures mass-to-charge ratio. The output is a mass, compared against the mass calculated from the intended sequence and molecular formula. It is fundamentally a weighing exercise, and weight is a property of identity rather than proportion.
The two results side by side
| Reverse-phase HPLC | Mass spectrometry | |
|---|---|---|
| Question | How much of the main component is present? | Is this the intended molecule? |
| Measures | Peak area, retention time | Mass-to-charge ratio |
| Reports | Purity as a percentage | Observed mass against calculated mass |
| Detects a wrong molecule at high purity | No | Yes |
| Detects a mixture of two similar peptides | Often, as two peaks | Depends on resolution and ionisation |
| Quantifies non-UV-absorbing mass | No | No |
The fourth row is the one that matters most and is quoted least. A synthesis that produced the wrong sequence cleanly will produce a single sharp peak and an excellent purity figure. Purity describes homogeneity, not correctness. Without a mass confirming identity, a high purity number establishes only that the material is consistently something.
Where each one runs out
HPLC at 214–220 nm registers only material that absorbs in that window, so counterion, residual water and salts contribute no peak and are absent from the purity ratio. That limit is covered in more detail in the note on purity versus net peptide content elsewhere in this journal.
Mass spectrometry confirms that a molecule of the expected mass is present, but a mass is not unique to one arrangement of atoms. Isomers and certain substitutions can share a nominal mass, and ionisation efficiency varies between species, so an MS result is a strong identity check rather than an absolute one. In practice the two methods are run together because each covers a gap the other leaves.
What neither method measures
Both are chemical assays. Neither detects bacterial endotoxin, viable microorganisms, or other pyrogenic material, because none of that is what they are built to see. Endotoxin is determined by a separate assay, and sterility by another again. They are different disciplines, run on different equipment, reported separately.
This is worth stating directly rather than leaving as an inference, because the omission is easy to read as coverage. A specification listing HPLC purity and an MS-confirmed mass is a complete chemical characterisation and an empty microbiological one. Aurum Bio publishes HPLC purity figures and does not perform or claim sterility or endotoxin testing.
Reading a specification that lists both
- A purity percentage with no method or wavelength is a number without a unit — the figure is uninterpretable until the assay is named.
- An identity claim with no observed mass is an assertion, not a result.
- Observed mass should be reported against calculated mass, not merely described as consistent.
- Purity and net peptide content are different quantities; a single percentage cannot be both.
- Absence of a microbiological result is not a negative result. It is silence.
References
- 01Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods in Molecular Biology, 2007.
- 02Aebersold R, Mann M Mass spectrometry-based proteomics. Nature, 2003.
- 03United States Pharmacopeia Bacterial Endotoxins Test. General Chapter <85>.
Every citation links out to the paper on PubMed. Identifiers are omitted deliberately rather than reproduced from memory, so where we do not hold a verified PMID or DOI the link is a PubMed search for that exact title — it resolves to the paper without anything being invented.
FOR RESEARCH USE ONLY · NOT INTENDED FOR HUMAN CONSUMPTION. This article describes compounds and the research literature in which they appear. Nothing here is a recommendation, protocol, or statement of effect.